• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

MEDMIX AG

Notes

No. Proposition For Against Abstain
1

Business review, financial statements of medmix Ltd and consolidated financial statements 2025

2

Advisory vote on the compensation report 2025

3

Sustainability report 2025

4

Appropriation of annual result

5

Discharge

6

Approval of the maximum aggregate amount of compensation of the Board of Directors

7

Approval of the maximum aggregate amount of compensation of the Executive Committee

8

Re-election of Mr. Rob ten Hoedt as member and Chairman of the Board of Directors

9

Re-election of Mr. Marco Musetti as member of the Board of Directors

10

Re-election of Ms. Barbara Angehrn as member of the Board of Directors

11

Re-election of Ms. Susanne Hundsbaek-Pedersen as member of the Board of Directors

12

Re-election of Mr. Daniel Flammer as member of the Board of Directors

13

Re-election of Mr. David Metzger as member of the Board of Directors

14

Re-election of Ms. Barbara Angehrn as member of the Nomination & Remuneration Committee

15

Re-election of Mr. Rob ten Hoedt as member of the Nomination & Remuneration Committee

16

Re-election of Mr. David Metzger as member of the Nomination & Remuneration Committee

17

Re-election of the Auditor

18

Re-election of the Independent Proxy

19

Transact Other Business